News

Consumer Edge Enhances Data Capabilities Through Earnest Deal

Consumer Edge Enhances Data Capabilities Through Earnest Deal

Consumer Edge Expands Its Data Reach

Consumer Edge, recognized as a leader in consumer alternative data intelligence, has recently completed an acquisition that marks a significant milestone in the data landscape. This acquisition involves Earnest Analytics, a company celebrated for its pioneering contributions to transaction and healthcare data solutions. By bringing Earnest within its fold, Consumer Edge is poised to enhance its offerings in providing precise and actionable global consumer spending data to diverse clients, including financial institutions and corporations around the world.

Strengthening Market Position with New Insights

The integration of Earnest Analytics empowers Consumer Edge to deepen its capabilities in delivering real-time insights into consumer and healthcare trends. Bill Pecoriello, the Chief Executive Officer and Founder of Consumer Edge, emphasizes the advantage this merger brings, stating, "Joining forces with Earnest enables us to offer our clients unmatched data and insights, allowing them to better understand consumer and healthcare industry trends and make smarter, more informed business and investment decisions." This collaborative effort involving two data-driven firms marks an exciting new chapter for both organizations.

Innovations in Data Intelligence

Consumer Edge's approach has always been rooted in enhancing customer experiences. With the addition of Earnest, the company plans to elevate the caliber of data they provide to their clients. Kevin Carson, Founder of Earnest Analytics, expressed his excitement over the union, stating, "Earnest and Consumer Edge share a deep commitment to providing the highest-quality data to our clients. This acquisition takes our combined insights to the next level." Both leaders demonstrate a shared vision of growth and innovation in data intelligence.

About Consumer Edge

Founded in 2009, Consumer Edge has built a reputation as a consumer-focused research boutique dedicated to customer service. The company has expanded over the years to become a leading provider of global consumer intelligence. Through actionable insights, they empower businesses to make informed decisions and drive success. Their commitment to understanding consumer behavior places them at the forefront of the data industry.

About Earnest Analytics

Established in 2012, Earnest Analytics specializes in measuring the consumer and healthcare economies using real-time data. Their structured datasets provide actionable insights tailored for a broad range of stakeholders, including institutional investors and government agencies. With advanced tools for analytics, they enable users to derive meaningful interpretations from complex data, ultimately aiding in strategic decision-making.

Media Contact Information

For any media inquiries, reach out to Caitlin Kasunich, Managing Director at KCSA Strategic Communications. Although specific contact details are not provided here, those interested in more information can refer to Consumer Edge’s official communications or their website.

Frequently Asked Questions

What does the acquisition of Earnest Analytics mean for Consumer Edge?

The acquisition enhances Consumer Edge's ability to offer better data insights and analytics, strengthening its market position and solutions for clients.

How will the merger impact Consumer Edge’s clients?

Clients will gain access to improved data and insights which will help in making more informed business and investment decisions.

What type of data does Earnest Analytics specialize in?

Earnest Analytics specializes in transaction and healthcare data, focusing on real-time insights into consumer and healthcare industries.

When was Consumer Edge founded?

Consumer Edge was founded in 2009 and has grown to become a prominent provider of consumer intelligence services.

Who should be contacted for media inquiries?

All media inquiries should be directed to Caitlin Kasunich, the Managing Director at KCSA Strategic Communications.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 337

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 296

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 416

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 195

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
D-Wave Investors Must Decide by Dec 15 Class Suit

Updated Category News Views 177

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 271

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 260

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 267

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading

Top 5 Most Recently Viewed Articles

Fluorescence Microscopy Market Growth to $1.3 Billion by 2029

Updated Category News Views 115

Fluorescence Microscopy Market Insights for 2029 "Life Sciences Propel Fluorescence Microscopy Market Growth Amid Rising Demand for Advanced Technologies" According to recent research, the global fluorescence microscopy market is projected to witness remarkable growth, moving from approximately $968.5 million in 2024 to reach $1.3 billion by 2029. This represents a...

Continue Reading
Vehicle Multimedia Quality Shows Positive Trends in Latest Study

Updated Category News Views 208

Enhanced Multimedia Quality in Vehicles: A Promising Trend Troy, Michigan, has seen a significant improvement in issues related to vehicle multimedia over the last five years. According to J.D. Power's extensive research, the number of problems per 100 vehicles (PP100) increased from 39.1 in 2020, reaching 43.7 in 2024. This indicates a consistent trend that, while...

Continue Reading
Titan Mining Unveils Impressive Q2 Growth and Future Prospects

Updated Category News Views 294

Titan Mining Reports Strong Q2 Performance Titan Mining Corporation (TIMCF) has recently released its financial and operational results for the quarter that ended June 30. The company met its quarterly production guidance at its Empire State Mines LLC (ESM) and is positioned to become the first complete producer of natural flake graphite in the United States by the end of...

Continue Reading
Spectra7 Microsystems Finalizes Asset Sale to Parade Technologies

Updated Category News Views 268

Spectra7 Microsystems Concludes Asset Sale with Parade Technologies Spectra7 Microsystems Inc. is excited to announce the successful closing of its significant asset sale to Parade Technologies, a notable supplier in the high-speed interface IC and video display markets. This transaction aims to enhance both companies' trajectories and enable Spectra7 to focus on its core...

Continue Reading
Exploring the Expanding Global Hydrogen Chloride Market Dynamics

Updated Category News Views 168

The Growing Landscape of the Hydrogen Chloride Market Recent analysis reveals that the hydrogen chloride market is on a remarkable upward trend, projected to escalate in value from US$ 2,824.08 million in 2024 to an impressive US$ 4,248.14 million by 2033. This growth trajectory indicates a steady CAGR of 4.75% throughout the projected years. Consumption Trends and Demand...

Continue Reading